The August 2008 issue of Diabetic Medicine includes a UKPDS Supplement, edited by Rury Holman and Peter Watkins. This Supplement contains eleven specially commissioned articles that review many of the contributions that have been made by UKPDS in different areas of interest. It puts these into context ahead of the late-breaking presentation of the 30-year follow-up data at the EASD in Rome on the 10th September 2008.
Impact of the UKPDS-an overview.
P. D. Home
Glucose control in the UKPDS: what did we learn?
E. A. M. Gale
The Hypertension in Diabetes Study (HDS): a catalyst for change.
Microvascular disease: what does the UKPDS tell us about diabetic retinopathy?
E. M. Kohner
Microvascular disease: what does the UKPDS tell us about diabetic nephropathy?
Autoimmune diabetes in adults: lessons from the UKPDS.
M. Desai, A. Clark
Genetics: how the UKPDS contributed to determining the genetic landscape of Type 2 diabetes.
A. L. Gloyn, M. I. McCarthy
UKPDS-modelling of cardiovascular risk assessment and lifetime simulation of outcomes.
A. I. Adler
The economic analyses of the UK prospective diabetes study.
A. M. Gray, P. Clarke
Ethnic diversity in Type 2 diabetes.
T. M. E. Davis
The UKPDS and its global impact.